{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:30:52Z","timestamp":1791178252281,"version":"4.1.0"},"reference-count":46,"publisher":"Rockefeller University Press","issue":"12","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1998,12,21]]},"abstract":"<jats:p>An endothelial cell inhibitor was purified from supernatant of an Epstein-Barr virus\u2013immortalized cell line and identified as fragments of calreticulin. The purified recombinant NH2-terminal domain of calreticulin (amino acids 1\u2013180) inhibited the proliferation of endothelial cells, but not cells of other lineages, and suppressed angiogenesis in vivo. We have named this NH2-terminal domain of calreticulin vasostatin. When inoculated into athymic mice, vasostatin significantly reduced growth of human Burkitt lymphoma and human colon carcinoma. Compared with other inhibitors of angiogenesis, vasostatin is a small, soluble, and stable molecule that is easy to produce and deliver. As an angiogenesis inhibitor that specifically targets proliferating endothelial cells, vasostatin has a unique potential for cancer treatment.<\/jats:p>","DOI":"10.1084\/jem.188.12.2349","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:49:30Z","timestamp":1027702170000},"page":"2349-2356","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":247,"title":["Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth"],"prefix":"10.1084","volume":"188","author":[{"given":"Sandra E.","family":"Pike","sequence":"first","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yao","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen D.","family":"Jones","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Cherney","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Appella","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyasu","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Nakhasi","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wirth","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Gupta","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Tosato","sequence":"additional","affiliation":[{"name":"From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the \u2021Laboratory of Cell Biology, the \u00a7Laboratory of Pathology, and the \u2016Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[1998,12,21]]},"reference":[{"key":"2023072508074364400_B1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1749-6632.1982.tb25720.x","article-title":"Angiogenesis: initiation and control","volume":"401","author":"Folkman","year":"1982","journal-title":"Ann NY Acad Sci"},{"key":"2023072508074364400_B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"2023072508074364400_B3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor\u2013induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"2023072508074364400_B4","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508074364400_B5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1197-1222","article-title":"Halting angiogenesis suppresses carcinoma cell invasion","volume":"3","author":"Skobe","year":"1997","journal-title":"Nat Med"},{"key":"2023072508074364400_B6","doi-asserted-by":"crossref","first-page":"17703","DOI":"10.1016\/S0021-9258(18)45436-1","article-title":"Biosynthetic and functional properties of an Arg-Gly-Asp\u2013directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor","volume":"262","author":"Cheresh","year":"1987","journal-title":"J Biol Chem"},{"key":"2023072508074364400_B7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin ab3for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"2023072508074364400_B8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin \u03b1 v \u03b2 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"Brooks","year":"1994","journal-title":"Cell"},{"key":"2023072508074364400_B9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"2023072508074364400_B10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nm0696-689","article-title":"Angiostatin induces and sustains dormancy of human primary tumors in mice","volume":"2","author":"O'Reilly","year":"1996","journal-title":"Nat Med"},{"key":"2023072508074364400_B11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"2023072508074364400_B12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"key":"2023072508074364400_B13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/87.8.581","article-title":"Inhibition of angiogenesis in vivo by interleukin 12","volume":"87","author":"Voest","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"2023072508074364400_B14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.182.1.155","article-title":"Human interferon\u2013inducible protein 10 is a potent inhibitor of angiogenesis in vivo","volume":"182","author":"Angiolillo","year":"1995","journal-title":"J Exp Med"},{"key":"2023072508074364400_B15","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1073\/pnas.93.24.13791","article-title":"Interferon-inducible protein 10 identified as a mediator of tumor necrosis in vivo","volume":"93","author":"Sgadari","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508074364400_B16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/bbrc.1995.1626","article-title":"Interferon gamma\u2013inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis","volume":"210","author":"Strieter","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2023072508074364400_B17","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood.V89.8.2635","article-title":"Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo","volume":"89","author":"Sgadari","year":"1997","journal-title":"Blood"},{"key":"2023072508074364400_B18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/endo.133.3.7689950","article-title":"The 16 kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis","volume":"133","author":"Clapp","year":"1993","journal-title":"Endocrinology"},{"key":"2023072508074364400_B19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"2023072508074364400_B20","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508074364400_B21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1688470","article-title":"Inhibition of angiogenesis by recombinant human platelet factor\u20134 and related peptides","volume":"247","author":"Maione","year":"1990","journal-title":"Science"},{"key":"2023072508074364400_B22","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1073\/pnas.87.17.6624","article-title":"A tumor suppressor\u2013dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin","volume":"87","author":"Good","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508074364400_B23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V83.3.776.776","article-title":"Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus\u2013immortalized human B cells","volume":"83","author":"Tosato","year":"1994","journal-title":"Blood"},{"key":"2023072508074364400_B24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10428199509107897","article-title":"Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus\u2013immortalized B cells","volume":"19","author":"Angiolillo","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"2023072508074364400_B25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF02628957","article-title":"Long-term culture of human endothelial cells","volume":"19","author":"Gordon","year":"1983","journal-title":"In Vitro"},{"key":"2023072508074364400_B26","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.4049\/jimmunol.140.12.4329","article-title":"Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-\u03b2 2\/B cell stimulatory factor 2\/IL-6","volume":"140","author":"Tosato","year":"1988","journal-title":"J Immunol"},{"key":"2023072508074364400_B27","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.4049\/jimmunol.137.6.2037","article-title":"Epstein-Barr virus immortalization of normal cells of B cell lineage with nonproductive, rearranged immunoglobulin genes","volume":"137","author":"Tosato","year":"1986","journal-title":"J Immunol"},{"key":"2023072508074364400_B28","first-page":"2508","article-title":"Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells","volume":"57","author":"Cherney","year":"1997","journal-title":"Cancer Res"},{"key":"2023072508074364400_B29","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/elps.11501601321","article-title":"Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins","volume":"16","author":"Wirth","year":"1995","journal-title":"Electrophoresis"},{"key":"2023072508074364400_B30","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1128\/jvi.67.12.7106-7117.1993","article-title":"5\u2032 sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins","volume":"67","author":"Pogue","year":"1993","journal-title":"J Virol"},{"key":"2023072508074364400_B31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/elps.1150180313","article-title":"Rapid mass spectrometric identification of proteins from two-dimensional polyacrylamide gels after in gel proteolytic digestion","volume":"18","author":"Li","year":"1997","journal-title":"Electrophoresis"},{"key":"2023072508074364400_B32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"2023072508074364400_B33","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1128\/jvi.69.6.3848-3851.1995","article-title":"The rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain","volume":"69","author":"Atreya","year":"1995","journal-title":"J Virol"},{"key":"2023072508074364400_B34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj2850681","article-title":"Calreticulin","volume":"285","author":"Michalak","year":"1992","journal-title":"Biochem J"},{"key":"2023072508074364400_B35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00925962","article-title":"Calreticulin: not just another calcium-binding protein","volume":"135","author":"Nash","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"2023072508074364400_B36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0092-8674(00)81884-X","article-title":"Calreticulin","volume":"88","author":"Krause","year":"1997","journal-title":"Cell"},{"key":"2023072508074364400_B37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/386843a0","article-title":"Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion","volume":"386","author":"Coppolino","year":"1997","journal-title":"Nature"},{"key":"2023072508074364400_B38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/367476a0","article-title":"Modulation of gene expression by calreticulin binding to the glucocorticoid receptor","volume":"367","author":"Burns","year":"1994","journal-title":"Nature"},{"key":"2023072508074364400_B39","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1074\/jbc.270.14.8179","article-title":"Calreticulin, an antithrombotic agent which binds to vitamin K-dependent coagulation factors, stimulates endothelial nitric oxide production, and limits thrombosis in canine coronary arteries","volume":"270","author":"Kuwabara","year":"1995","journal-title":"J Biol Chem"},{"key":"2023072508074364400_B40","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1476-5381.1994.tb14822.x","article-title":"Evidence that nitric oxide is an endogenous antiangiogenic mediator","volume":"111","author":"Pipili-Synetos","year":"1994","journal-title":"Br J Pharmacol"},{"key":"2023072508074364400_B41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1006\/bbrc.1996.0654","article-title":"Nitric oxide inhibits migration of cultured endothelial cells","volume":"221","author":"Lau","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2023072508074364400_B42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4049\/jimmunol.161.2.927","article-title":"The CXC chemokines IP-10 and Mig are necessary for IL-12\u2013mediated regression of the mouse RENCA tumor","volume":"161","author":"Tannenbaum","year":"1998","journal-title":"J Immunol"},{"key":"2023072508074364400_B43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jlb.64.3.384","article-title":"Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12","volume":"64","author":"Kanegane","year":"1998","journal-title":"J Leuko Biol"},{"key":"2023072508074364400_B44","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1073\/pnas.95.11.6343","article-title":"A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1","volume":"95","author":"Volpert","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072508074364400_B45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1074\/jbc.271.1.21","article-title":"Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin","volume":"271","author":"Gao","year":"1996","journal-title":"J Biol Chem"},{"key":"2023072508074364400_B46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nm0198-013","article-title":"A flanking attack on cancer","volume":"4","author":"Hanahan","year":"1998","journal-title":"Nat Med"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/188\/12\/2349\/1689367\/98-1559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/188\/12\/2349\/1689367\/98-1559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T09:10:41Z","timestamp":1690276241000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/188\/12\/2349\/7688\/Vasostatin-a-Calreticulin-Fragment-Inhibits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12,21]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12,21]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.188.12.2349","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12,21]]}}}